CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-19 | Kumar Neil Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +71,208 | 71,208 | ||
| 2025-03-19 | Kumar Neil Chief Executive Officer | Grant or award · Restricted Stock Units | +184,860 | 184,860 | ||
| 2025-03-19 | Apuli Maricel Chief Accounting Officer | Grant or award | +23,660 | 148,665 | ||
| 2025-03-06 | Valantine Hannah Director | Option exercise 10b5-1 | +12,875 | $16.75 | $216K | 14,639 |
| 2025-03-06 | Valantine Hannah Director | Sale 10b5-1 | −12,875 | $32.58 | $419K | 1,764 |
| 2025-03-06 | Valantine Hannah Director | Option exercise · Stock Option (right to buy) 10b5-1 | −12,875 | 38,626 | ||
| 2025-03-05 | KKR Genetic Disorder L.P. 10% owner | Sale | −6,000,000 | $32.96 | $197.8M | 19,260,971 |
| 2025-02-25 | STEPHENSON BRIAN C CFO and Treasurer | Option exercise 10b5-1 | +8,500 | $17.00 | $145K | 110,964 |
| 2025-02-25 | STEPHENSON BRIAN C CFO and Treasurer | Sale 10b5-1 | −8,400 | $33.18 | $279K | 102,564 |
| 2025-02-25 | STEPHENSON BRIAN C CFO and Treasurer | Sale 10b5-1 | −100 | $34.18 | $3K | 102,464 |
| 2025-02-25 | STEPHENSON BRIAN C CFO and Treasurer | Option exercise · Stock Option (right to buy) 10b5-1 | −8,500 | 440,170 | ||
| 2025-02-25 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −37,899 | $33.36 | $1.3M | 5,060,548 |
| 2025-02-25 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −37,101 | $33.79 | $1.3M | 5,023,447 |
| 2025-02-19 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Sale 10b5-1 | −4,148 | $36.16 | $150K | 102,464 |
| 2025-02-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −31,467 | $36.14 | $1.1M | 211,794 |
| 2025-02-19 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −76 | $36.56 | $3K | 211,718 |
| 2025-02-16 | Trimarchi Thomas President and COO | Shares withheld for taxes | −13,782 | $34.90 | $481K | 414,205 |
| 2025-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise 10b5-1 | +25,798 | 119,714 | ||
| 2025-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Shares withheld for taxes 10b5-1 | −13,102 | $34.90 | $457K | 106,612 |
| 2025-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Restricted Stock Units 10b5-1 | −779 | 0 |
Page 20 of 32 · 638 trades